Head-to-head · WeighScore
Always Wellness and Recovery vs Zealthy
The verdict
Always Wellness and Recovery takes it — 57.5/100 to 46.7/100.
Always Wellness and Recovery grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Always Wellness and Recovery is a nationwide telehealth platform offering physician-prescribed compounded semaglutide and tirzepatide with personalized dosing and no mandatory subscription.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Always Wellness and Recovery | Zealthy |
|---|---|---|
| WeighScore | 57.5/100 | 46.7/100 |
| Grade | C | C |
| Scorecard rank | #395 | #496 |
| Semaglutide | Not disclosed | $286/mo (starting dose, plus a separate fee, compounded) |
| Tirzepatide | Not disclosed | $351/mo (starting dose, plus a separate fee, compounded) |
| Coverage | Coverage not published | 34 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #395 · C
Strengths
- Compounded semaglutide and tirzepatide with personalized dosing, not one-size-fits-all
- No mandatory subscription — cancel anytime
- Every case reviewed by a board-certified US physician (medical director Dr. M. Reyes, MD)
- Unlimited HIPAA-secure messaging with the care team
- Lab work included where clinically indicated; free discreet shipping in 3-5 days
Where it loses points
- Pricing is not shown until you complete an application
- Compounded GLP-1s are not FDA-approved finished products
- No LegitScript certification visible and the compounding pharmacy is not named
- Cash-pay only — no insurance billing
Graded #496 · C
Strengths
- Serves 34 states — meaningful nationwide footprint
- Asynchronous model removes friction for patients who don't want a video visit
- Independent licensed prescribers retain full clinical authority
Where it loses points
- Active Novo Nordisk false-advertising lawsuit alleging trademark infringement and marketing compounded drugs as FDA-approved alternatives
- Active DOJ/FTC enforcement alleging undisclosed subscription terms, locked cancellation, and unauthorized health-data sharing
- Founder previously ran Cerebral, which settled with the FTC in 2024 over similar deceptive practices
- Recently rebranded to Gronk Inc. amid active enforcement
- FDA issued this company a warning letter dated 1 September 2025; the letter is public in FDA's warning-letter database
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.